Task: Answer the multiple-choice question.
Question: Which drug exhibits a 18.268\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CN1CCN(c2ccccc2/C=N/NC(=O)c2cccnc2)CC1
b. COCCn1c(SCC(=O)NC2CCCCC2)nnc1-c1ccco1
c. Cc1ccc(C(=O)NCCCc2ccccc2)c(C)c1
d. CCn1ccnc1CN(C)Cc1cn(-c2ccccc2)nc1-c1ccc(OC)cc1F
Answer: a. CN1CCN(c2ccccc2/C=N/NC(=O)c2cccnc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(c2ccccc2/C=N/NC(=O)c2cccnc2)CC1
CN1CCN(c2ccccc2/C=N/NC(=O)c2cccnc2)CC1
N-[(E)-[2-(4-methylpiperazin-1-yl)phenyl]methylideneamino]pyridine-3-carboxamide